BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 6363157)

  • 1. Acidrine in the management of gastritis and duodenitis. A double-blind placebo controlled clinical trial.
    Galeone M; Cacioli D; Toti GL; Moise G; Megevand J; Benazzi E; Michetti F
    J Int Med Res; 1984; 12(1):51-5. PubMed ID: 6363157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Acidrine in the treatment of diseases caused by hydrochloropeptic hypersecretion].
    Corazza GR; Pesa O; Frazzoni M; Frisoni M; Milletti S; Vaira D
    Minerva Dietol Gastroenterol; 1981; 27(4):585-91. PubMed ID: 7335232
    [No Abstract]   [Full Text] [Related]  

  • 3. Cimetidine in the management of symptomatic patients with duodenitis: a double-blind controlled trial.
    Mackinnon M; Willing RL; Whitehead R
    Dig Dis Sci; 1982 Mar; 27(3):217-9. PubMed ID: 7042248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Use of Acridine in a pneumology department].
    Macquet V; Rogeaux Y; Lafitte P
    Lille Med; 1976 Jan; 21(1 suppl 1):16. PubMed ID: 1256226
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of peptic ulcer. Clinical-statistical evaluation of the effects of an antacid-antipeptic and contact anesthetic combination (Acidrine)].
    D'Agostino L; Mazzacca G
    Minerva Dietol Gastroenterol; 1978; 24(4):349-52. PubMed ID: 757278
    [No Abstract]   [Full Text] [Related]  

  • 6. A controlled trial of cimetidine for the treatment of nonulcer dyspepsia.
    Lance P; Wastell C; Schiller KF
    J Clin Gastroenterol; 1986 Aug; 8(4):414-8. PubMed ID: 3531314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Helicobacter pylori eradication--comparison of three drug regimens and symptomatic assessment in duodenitis and antral gastritis.
    Tan WC; Hogan J; Purkayastha SK; Lombard M; Krasner N
    Int J Clin Pract; 1997 Jun; 51(4):214-6. PubMed ID: 9287260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-dose antacids and pirenzepine in the treatment of patients with non-ulcer dyspepsia and erosive prepyloric changes. A randomized, double-blind, placebo-controlled trial.
    Weberg R; Berstad A
    Scand J Gastroenterol; 1988 Mar; 23(2):237-43. PubMed ID: 3283918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pirenzepine in the treatment of benign gastroduodenal diseases. A double-blind controlled clinical trial.
    Gasbarrini G; Giorgi-Conciato M; D'Anchino M; Di Tommaso B; Pesa O; Sollecito A; Cifani G
    Scand J Gastroenterol Suppl; 1979; 57():25-31. PubMed ID: 396654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-Siglec-8 Antibody for Eosinophilic Gastritis and Duodenitis.
    Dellon ES; Peterson KA; Murray JA; Falk GW; Gonsalves N; Chehade M; Genta RM; Leung J; Khoury P; Klion AD; Hazan S; Vaezi M; Bledsoe AC; Durrani SR; Wang C; Shaw C; Chang AT; Singh B; Kamboj AP; Rasmussen HS; Rothenberg ME; Hirano I
    N Engl J Med; 2020 Oct; 383(17):1624-1634. PubMed ID: 33085861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sucralfate therapy in patients with symptoms of alkaline reflux gastritis. A randomized, double-blind study.
    Buch KL; Weinstein WM; Hill TA; Elashoff JD; Reedy TJ; Ippoliti AF; Tedesco FJ; Singh M
    Am J Med; 1985 Aug; 79(2C):49-54. PubMed ID: 3839973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A double-blind, short-term clinical trial of pirenzepine in duodenal ulcer.
    Morelli A; Narducci F; Pelli MA; Spadacini A
    Scand J Gastroenterol Suppl; 1979; 57():45-9. PubMed ID: 396657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Use of a prostaglandin derivative in the treatment of gastroduodenal ulcer and gastroduodenitis].
    Germiniani R; Fichera G; Siardi C; Biolchi S; Zennaro F
    Minerva Dietol Gastroenterol; 1987; 33(2):169-80. PubMed ID: 3627525
    [No Abstract]   [Full Text] [Related]  

  • 14. Campylobacter pylori-associated gastritis: a double-blind placebo-controlled trial with amoxycillin.
    Glupczynski Y; Burette A; Labbe M; Deprez C; De Reuck M; Deltenre M
    Am J Gastroenterol; 1988 Apr; 83(4):365-72. PubMed ID: 3279757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A placebo-controlled, double-blind study of sucralfate in the short-term treatment of duodenal ulcer.
    Sung JL; Yu JY; Wang TH; Wang CY; Chen DS
    Scand J Gastroenterol Suppl; 1983; 83():21-4. PubMed ID: 6356317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of cimetidine in patients with non-ulcer dyspepsia and erosive prepyloric changes.
    Nesland AA; Berstad A
    Scand J Gastroenterol; 1985 Jun; 20(5):629-35. PubMed ID: 3895384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [On the pathogenesis and treatment of erosive gastritis and duodenitis].
    Vakhrushev IaM; Nikishina EV
    Klin Med (Mosk); 1999; 77(2):28-31. PubMed ID: 10380457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between active peptic ulcer, endoscopic duodenitis and symptomatic state after treatment with cimetidine.
    Danielsson A; Ek B; Nyhlin H; Steen L
    Ann Clin Res; 1980 Feb; 12(1):4-12. PubMed ID: 6990861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controlled clinical trial with sucralfate in the treatment of macroscopic gastritis.
    Skoubo-Kristensen E; Funch-Jensen P; Kruse A; Hanberg-Sørensen F; Amdrup E
    Scand J Gastroenterol; 1989 Aug; 24(6):716-20. PubMed ID: 2683019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Misoprostol for the treatment of chronic erosive gastritis: a double-blind placebo-controlled trial.
    Pazzi P; Gamberini S; Scagliarini R; Dalla Libera M; Merighi A; Gullini S
    Am J Gastroenterol; 1994 Jul; 89(7):1007-13. PubMed ID: 8017357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.